| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/17/2008 | WO2005037999A3 Treatment of cancer using antibodies to lrrc15 |
| 01/17/2008 | WO2005021726A3 Immunogenic hiv compositions and related methods |
| 01/17/2008 | WO2005021710A3 Chimeric molecules and methods of use |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 01/17/2008 | US20080014624 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs |
| 01/17/2008 | US20080014281 Chitin Micro-Particles As An Adjuvant |
| 01/17/2008 | US20080014260 Solid dispersing vaccine composition for oral delivery |
| 01/17/2008 | US20080014254 Stable Crystal Modifications of Dotap Chloride |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014222 Cancer immunotherapy compositions and methods of use |
| 01/17/2008 | US20080014221 Mycoplasma hyopneumoniae vaccine |
| 01/17/2008 | US20080014220 Vaccine Against Hpv16 And Hpv18 And At Least Another Hpv Type Selected From Hpv 31, 45 Or 52 |
| 01/17/2008 | US20080014219 Method of immunization against the 4 dengue serotypes |
| 01/17/2008 | US20080014218 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 01/17/2008 | US20080014217 Influenza vaccine |
| 01/17/2008 | US20080014216 Vaccination with a live viral vaccine (prime) is followed by vaccination with an inactivated vaccine (boost) for the same virus, wherein the two shots are given no longer than 8 weeks apart; protection of horses against equine influenza virus (EIV) or equine herpes virus (EHV) |
| 01/17/2008 | US20080014215 Animal Bioreactors |
| 01/17/2008 | US20080014214 Composition and Method for Inducing Protective Vaccine Response Using SDF-1 |
| 01/17/2008 | US20080014212 Cloned genomes of infectious hepatitis C viruses and uses thereof |
| 01/17/2008 | US20080014211 Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic and therapeutic purposes |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014209 Peptide mimics of conserved Gonococcal epitopes and methods and compositions using them |
| 01/17/2008 | US20080014208 Fusion proteins, uses thereof and processes for producing same |
| 01/17/2008 | US20080014207 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 01/17/2008 | US20080014206 drug screening for agents potentially useful in the treatment of Mycobacterium tuberculosis infection; drug resistant antibiotics |
| 01/17/2008 | US20080014205 Neutralizing Antibodies to Influenza Viruses |
| 01/17/2008 | US20080014204 Compositions Against Sars-Coronavirus and Uses Thereof |
| 01/17/2008 | US20080014203 Immunoglobulin which binds insulin-like growth factor receptor (IGF-IR ) for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 01/17/2008 | US20080014202 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 01/17/2008 | US20080014201 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 01/17/2008 | US20080014200 Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents |
| 01/17/2008 | US20080014199 Assessing Cancer And Vimentin |
| 01/17/2008 | US20080014198 Treatment of Cancer With a Combination of an Agent that Perturbs the EGF Signaling Pathway and an Oligonucleotide that Reduces Clusterin Levels |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014196 Compositions and methods for modulating vascular development |
| 01/17/2008 | US20080014195 Antagonists Of Myelin-Associated Glycoprotein And Their Use In The Treatment And/Or Prevention Of Neurological Diseases |
| 01/17/2008 | US20080014194 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent and treat parkinson's disease |
| 01/17/2008 | US20080014192 Methods For The Diagnosis And Treatment of Fungal Infections Caused By Microorganisms Producing Glucosylceramide |
| 01/17/2008 | US20080014191 Treatment of Protein Misfolding |
| 01/17/2008 | US20080014188 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 01/17/2008 | US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein |
| 01/17/2008 | US20080014182 Populations of Expanded and Re-Differentiated Adult Islet Beta Cells Capable of Producing Insulin and Methods of Generating Same |
| 01/17/2008 | US20080014180 Hemangio-colony forming cells |
| 01/17/2008 | US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte |
| 01/17/2008 | US20080014159 Therapy for melanin related afflictions |
| 01/17/2008 | US20080014143 Methods and compositions for targeting gC1qR/p32 |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | CA2662905A1 Compositions and methods for inhibiting growth of smad4-deficient cancers |
| 01/17/2008 | CA2659392A1 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
| 01/17/2008 | CA2658241A1 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | CA2658222A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using .gamma. .delta. t cell activators |
| 01/17/2008 | CA2657771A1 Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes |
| 01/17/2008 | CA2657648A1 Virosomes, methods of preparation, and immunogenic compositions |
| 01/17/2008 | CA2657385A1 Cell death inducer |
| 01/17/2008 | CA2657277A1 Process for preparing particles of proteinaceous material |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2656349A1 Method of immunisation against the four serotypes of dengue |
| 01/17/2008 | CA2583555A1 Influenza vaccine |
| 01/17/2008 | CA2551163A1 Methods for treating inflammatory, autoimmune or bone resorption diseases |
| 01/16/2008 | EP1878797A2 Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same |
| 01/16/2008 | EP1878796A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878795A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878794A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878749A2 Individulized anti-cancer antibodies |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878746A2 Human monoclonal antibodies to epidermal growth factor receptor |
| 01/16/2008 | EP1878742A2 HIV peptides, antigens, vaccine compositions, immunoassay and a method of detecting antibodies induced by HIV |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878440A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds |
| 01/16/2008 | EP1878439A2 Actinobacillus pleuropneumoniae virulence genes |
| 01/16/2008 | EP1878424A2 Novel vaccine |
| 01/16/2008 | EP1877558A1 Preparation of soluble n-protein/truncated p-protein complexes or n-proteins soluble in a virus of the paramyxoviridae family and use thereof in vaccines |
| 01/16/2008 | EP1877549A2 Hiv vaccine |
| 01/16/2008 | EP1877540A1 Use of nk cell inhibition to facilitate persistence of engrafted mhc- i negative cells |
| 01/16/2008 | EP1877539A1 Mutant f. tularensis strain and uses thereof |
| 01/16/2008 | EP1877444A2 P-cadherin antibodies |
| 01/16/2008 | EP1877440A2 Recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 01/16/2008 | EP1877426A2 Novel method for preventing or treating m tuberculosis infection |
| 01/16/2008 | EP1877421A2 Single-chain antibody with cleavable linker |
| 01/16/2008 | EP1877088A2 Vaccine against pandemic strains of influenza viruses |
| 01/16/2008 | EP1877087A1 Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
| 01/16/2008 | EP1877086A2 Vaccine |
| 01/16/2008 | EP1877085A1 Coccidial vaccine and methods of making and using same |
| 01/16/2008 | EP1877084A2 Method for the isolation of spiroplasma in mammals |
| 01/16/2008 | EP1877083A2 Antibodies for the treatment of cancers |
| 01/16/2008 | EP1877082A2 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1713501B1 Treatment of neurodegenerative diseases by the use of gpr49 |
| 01/16/2008 | EP1457559B1 Artificial antibody library with super-repertory |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1326639B1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/16/2008 | EP1255562B1 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 01/16/2008 | EP1228193B1 Feline calicivirus genes and vaccines, in particular recombined vaccines |